DR. STEPHAN B ROSENFELD M.D. NPI 1083685283

NPI Information

  • NPI: 1083685283
  • Provider Name: DR. STEPHAN B ROSENFELD, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3232 N NORTHHILLS BLVD
    FAYETTEVILLE, AR
    ZIP 72703
  • Phone: (479) 587-1700

Map and Directions

Get Directions

NPI Details

DR. Stephan B Rosenfeld, M.D. is a hematology and oncology internal medicine in Fayetteville, AR with 30 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Stephan B Rosenfeld, M.D. NPI is 1083685283. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: R FRANKLIN UNIVERSITY OF MED & SCI/CHICAGO MEDICAL SCHOOL
Graduation Year:1996

The provider's business location address is:

3232 N NORTHHILLS BLVD
FAYETTEVILLE, AR
ZIP 72703-005
Phone: (479) 587-1700
Fax: (479) 587-1366

The NPI 1083685283 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
  • Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
  • Injection, pemetrexed, not otherwise specified, 10 mg (HCPCS:J9305)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
  • Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Uric acid level, blood (HCPCS:84550)
  • Magnesium level (HCPCS:83735)
  • Phosphate level (HCPCS:84100)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Bilirubin level, direct (HCPCS:82248)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, etoposide, 10 mg (HCPCS:J9181)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Unclassified drugs (HCPCS:J3490)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg (HCPCS:Q5108)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Blood creatinine level (HCPCS:82565)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Blood test, clotting time (HCPCS:85610)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Cortisol (hormone) measurement, total (HCPCS:82533)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Hospital discharge day management, 30 minutes or less (HCPCS:99238)
  • Vitamin d-3 level (HCPCS:82306)
  • Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Administration of chemotherapy into vein using push technique (HCPCS:96409)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • X-ray of chest, 2 views (HCPCS:71046)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of prolonged chemotherapy into vein (HCPCS:96416)
  • Injection, meperidine hydrochloride, per 100 mg (HCPCS:J2175)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month (HCPCS:98980)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Fee covid-19 vac 14 res (HCPCS:0134A)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Glutamyltransferase (liver enzyme) level (HCPCS:82977)
  • Mri scan of brain before and after contrast (HCPCS:70553)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Red blood count, automated test (HCPCS:85045)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Limited ultrasound scan of abdomen (HCPCS:76705)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
  • Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)

The enumeration date for this NPI number is 1/27/2006 and was last updated on 3/30/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyE3326ARKANSASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1100177440AMEDICAIDOKLAHOMA
2146332001MEDICAIDARKANSAS
3205831407MEDICAIDMISSOURI

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.